Medical Marketing Whiz Earns 2021-22 Great Places to Work® Certification™

medical marketing agency

Medical Marketing Whiz

Medical Marketing Whiz employee survey results

Medical Marketing Whiz employee survey results

GTPW Medical Marketing Whiz

Medical Marketing Whiz Great Places to Work Award

Medical Marketing Whiz receives 100% employee satisfaction survey results and receives award from Great Places to Work

We are honored to become Great Place to Work-Certified™ as we consider employee satisfaction a top priority every day”

— Lori Werner

CANTON, MI, October 31, 2021 /EINPresswire.com/ — Medical Marketing Whiz, a leader in medical marketing for private practice physicians announced today that the company is now Certified™ by Great Place to Work® for 2021-22. The prestigious award is based entirely on what current employees say about their experience working at Medical Marketing Whiz. This year, 100% of employees said it’s a great place to work – 41 points higher than the average U.S. company.

Great Place to Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention, and increased innovation.

“Great Place to Work Certification™ isn’t something that comes easily – it takes ongoing dedication to the employee experience,” said Sarah Lewis-Kulin, vice president of global recognition at Great Place to Work. “It’s the only official recognition determined by employees’ real-time reports of their company culture. Earning this designation means that Medical Marketing Whiz is one of the best companies to work for in the country.”

“We are honored to become Great Place to Work-Certified™ as we consider employee satisfaction a top priority every day,” said Lori Werner, Co-Founder of Medical Marketing Whiz. “We collaborate. We laugh. We work hard every day. We celebrate and thank our employees for all they do to earn this incredible recognition.”

The Great Places to Work certification process includes a confidential employee survey. To certify as a great place to work, organizations must meet these requirements:

Seven out of ten employees must say on the Trust Index survey that it is a great place to work. Organizations must have a minimum of ten employees and the entire organization must participate, not just a single department.

According to Great Place to Work research, job seekers are 4.5 times more likely to find a great boss at a Certified great workplace. Additionally, employees at Certified workplaces are 93% more likely to look forward to coming to work, and are twice as likely to be paid fairly, earn a fair share of the company’s profits and have a fair chance at promotion.

WE’RE HIRING!
Looking to grow your career at a company that puts its people first? Visit our website or send resume to support@medicalmarketingwhiz.com

About MEDICAL MARKETING WHIZ

Medical Marketing Whiz is the leader in revenue-generating marketing services for OBGYN, urogynecology, aesthetics and concierge medicine providers. Lori Werner and Glenn Akins, co-founded Medical Marketing Whiz in 2018 and have quickly become one of the most sought-after marketing agencies in North America.

The company serves as an outsourced chief marketing officer for private practice physicians and serves as an extension of the client’s team, and provides services such as social media marketing, email marketing, reputation management, local search engine optimization and patient education events and webinars.

In addition to the Great Places to Work Certification, Medical Marketing Whiz was also recently named to DotCom magazine’s 2021 Impact Company Of The Year Awards, Company of the Year in the Healthcare Marketing edition of Healthcare Tech Outlook magazine, and the Health 2.0 Best Companies Award for 2021-22.

For more information visit https://www.medicalmarketingwhiz.com/

About Great Place to Work Certification™

Great Place to Work® Certification™ is the most definitive “employer-of-choice” recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place to Work-Certified.
About Great Place to Work®

Great Place to Work® is the global authority on workplace culture. Since 1992, they have surveyed more than 100 million employees worldwide and used those deep insights to define what makes a great workplace: trust. Their employee survey platform empowers leaders with the feedback, real-time reporting and insights they need to make data-driven people decisions. Everything they do is driven by the mission to build a better world by helping every organization become a great place to work For All™.

Learn more at greatplacetowork.com and on LinkedIn, Twitter, Facebook and Instagram.

Lori Werner
Medical Marketing Whiz
+1 888-418-8065
email us here
Visit us on social media:
Facebook
LinkedIn
Other


Source: EIN Presswire

CAR-T Cell Therapy Market Size, Share is Expected to Grow at CAGR 39.4% CAGR between 2021-2031

CAR-T Cell Therapy Market was valued at $0.234 Bn in 2020. Grow at a high CAGR of more than 39.4% by 2021 and 2031, it is estimated to reach $10.5 Bn by 2031.

MILWAUKEE, WISCONSIN, UNITED STATES, October 31, 2021 /EINPresswire.com/ — According to a new market research report published by sheer analytics and insights, “The Global CAR-T Cell Therapy Market was valued at $0.234 Billion in 2020. Growing at a high CAGR of more than 39.4% between 2021 and 2031, it is estimated to reach $10.5 Billion by 2031, as per the latest market research report titled CAR-T Cell Therapy Market- Industry analysis, size, share, growth, trends, and forecast, 2021-2031.

For many years, the foundations for cancer treatment have been chemotherapy, radiation therapy, and surgery. Over the past several years immunotherapy has emerged that enlist and strengthen the power of the patient’s immune system so that they can attack tumors. It is now also known as the “fifth pillar” of cancer treatment. However, recently researchers have come up with more advanced treatments for cancer, known as, CAR-T Cell therapy.

What is this CAR-T Cell therapy?

CAR-T Cell therapy is a variation of immunotherapy popularly known as adoptive cell therapy. The T cells are the type of white blood cell that is extracted by the doctor from the patient’s blood and then they add an artificial receptor to their surface. The receptor acts as a type of “heat-seeking missile” and this enables the modified cells to produce a type of chemicals that can kill cancer. Once they are infused back into the patient’s body through an IV, they start multiplying and attack tumor cells.

Click the full report at CAR-T Cell Therapy Market: https://www.sheeranalyticsandinsights.com/market-report-research/car-t-cell-therapy-market-21

The CAR-T cell is a type of antibody that induces modular-fusion protein having an extracellular specific binding domain. This therapy has made it possible to provide treatment against recurrence options for blood cancer and other carcinogenic cases. Needless to say, today CAR-T cell in the carcinogenic therapeutics field has become a boon to the healthcare industry. Owing to this factor many companies have started investing in CAR-T cell therapy which has increased its market and continues to do so. Presently, the most successful is the CD 19 antigen which is used for treating acute lymphoblastic leukemia (ALL). The Food and Drug Administration (FDA) has also approved the first genetic engineering which is based on Kymriah (tisagenlecleucel) by Novartis AG. Moreover, there are also other various clinical trials on the process by using the CAR-T cell therapy which can combat another kind of tumor and acute myeloid leukemia.

The major reason behind the rapid growth of the CAR-T cell therapy market is the intensified growth of cancer cases. Furthermore, the technological advancement in this field is also contributing and creating a huge potential for the growth of the market. However, the high price of the therapy packages and the longer period of their clinical trials is proving to be a barrier to the growth of the CAR-T cell market. As per market research, no more than 150 patients will be getting this treatment in 2020.

As per the segmentation of the regions in the report, the CAR-T cell therapy market is segmented into North America, Latin America, Europe, Middle East & Africa, and the Asia Pacific. However, the market is dominated by North America and Europe. The demand for CAR-T cell therapy is increasing in this region owing to the rising prevalence of disease, growing awareness among the people, the increase in geriatric population, and world-class diagnosis techniques. It is estimated that the market in the region of Asia Pacific will also increase during the forecasted period. The market over here is mainly driven by the rising awareness regarding cancer, advanced diagnosis laboratories, and the initiatives that are taken by the government to spread awareness among the people.

In the aforementioned market research report published by Sheer Analytics and Pvt. Ltd. the global CAR T cell therapy market has been categorized on the basis of targeted antigen, treatment, and geographical boundaries.

Click the Free PDF Sample Request at https://www.sheeranalyticsandinsights.com/request-sample/car-t-cell-therapy-market-21

The targeted segment includes– HER1, HER2, CD19, CD20, CD22, CD30, CD33, GD2, MESO, and EGFRvIII; the CD19 section is predicted to grab the major share of the global CAR-T cell therapy market due to its highest success rate in detecting and treating acute lymphoblastic leukemia (ALL). The treatment type segment includes non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), multiple myeloma, acute myeloid leukemia (AML), breast cancer, pancreatic cancer, neuroblastoma (NB), colon cancer, and hepatocellular carcinoma (HCC). Here, the acute lymphoblastic leukemia group is dominating the other diseases.

Leyland, a clinical biopharmaceutical company has focused on the development of CAR-T cell therapies, and they have announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) application for CYAD-101. This will be the first non-gene edited allogeneic clinical program.

The CEO of Ceylad, Dr. Christian Homsy told: “We are pleased to have achieved this important milestone. Celyad is the first company clinically evaluating a non-gene edited CAR-T candidate, which, we believe, offers significant advantages over gene-edited approaches. Our non-gene edited program consists of a family of technologies aimed at reducing or eliminating T cell receptor (TCR) signaling without requiring genetic manipulation. CYAD-101 is part of a robust clinical development plan, establishing the foundations of next-generation CAR-T products.”

The major companies operating in the global CAR-T cell therapy market are Novartis International AG, Kite Pharma Inc., Juno Therapeutics, Cellectis, Bellicum Pharmaceuticals Inc. and Celgene Corporation among others.

The global CAR-T Cell Therapy market has been segmented into:

Global CAR-T Cell Therapy Market: By Targeted Antigen

HER1
HER2
CD19
CD20
CD22
CD30
CD33
GD2
MESO and
EGFRvIII

Global CAR-T Cell Therapy Market: By Treatment

Non-Hodgkin lymphoma (NHL)
Chronic lymphocytic leukemia (CLL)
Acute lymphoblastic leukemia (ALL)
Multiple myelomas
Acute myeloid leukemia (AML)
Breast cancer
Pancreatic cancer
Neuroblastoma (NB)
Colon cancer and
Hepatocellular carcinoma (HCC)

Global CAR-T Cell Therapy Market: By Geography

North America
USA
Canada
Mexico
Rest of North America

Europe
UK
Germany
France
Spain
Italy
Russia
Rest of Europe

Asia Pacific
India
China
Japan
South Korea
Rest of Asia Pacific

Latin America, Middle East & Africa
Brazil
South Africa
UAE
Rest of LAMEA

Request Full Customization for Report: https://www.sheeranalyticsandinsights.com/ask-for-discount/car-t-cell-therapy-market

Browse Related Reports

Castrate-Resistant Prostate Cancer Market: https://www.sheeranalyticsandinsights.com/market-report-research/castrate-resistant-prostate-cancer-market-21

Systemic Scleroderma Treatment Market: https://www.sheeranalyticsandinsights.com/market-report-research/systemic-scleroderma-treatment-market-21

About Us

Sheer Analytics and Insights Private Limited is market research, consulting, and IT services company. We as a company believe in providing point to point data and its analysis with the combination of our human and automation integration. Sheer Analytics and Insights cover majorly eight industry verticals, including chemicals, life science, communications, and electronics, materials, consumer goods, defense, and BFSI sector.

Sheer Analytics believes in quality work and ensures that the product delivered to the client is meaningful for them. We publish reports based on our advanced analytics reports, which are generated with the help of our in-house databases, external databases, and artificial intelligence integration processes. We stand out from other market research companies in terms of integrating facts with meaningful insights for forecasting.

Apart from publishing syndicated reports (mostly client reports), we are dealing with projects primarily based on “Go to Market Strategy, Data Mining and Extraction,” meaning full data analysis based on big data and many other database services and content related services.

Our products include quick turnaround datasets, TAM/PAM Analysis to full-fledged deep dive research on top trending markets.

Website: https://www.sheeranalyticsandinsights.com/

Abhigyan Sengupta
Sheer Analytics and Insights Pvt. Ltd.
+1 4142405010
email us here


Source: EIN Presswire

Medical Marketing Whiz awarded the Health 2.0 Best Companies Award

medical marketing agency

Medical Marketing Whiz

medical marketing company

Medical Marketing Whiz team

Best Marketing Companies Award Medical Marketing Whiz

Best Marketing Companies Award Medical Marketing Whiz

Health 2.0 Conference will award Medical Marketing Whiz the best medical marketing agency award at their annual conference in April 2022 in Las Vegas

It’s always exciting to be recognized by a premier awards program, and it validates our mission to deliver excellence in marketing and contribute to patient education and outreach in women’s health.”

— Lori Werner

CANTON, MICHIGAN, UNITED STATES, October 31, 2021 /EINPresswire.com/ — Medical Marketing Whiz, a leader in medical marketing for private practice physicians announced today that the company was named the Health 2.0 Best Companies Award, a program honoring excellence in healthcare services and marketing. Medical Marketing Whiz will accept the award at the 2022 Health 2.0 Conference in Las Vegas in April.

“It’s always exciting to be recognized by a premier awards program, and it validates our mission to deliver excellence in marketing for our doctors and contribute to patient education and outreach in women’s health”, said Lori Werner, Co-Founder of Medical Marketing Whiz.

The Health 2.0 Conference assessment committee rated companies on a number of factors, such as industry reputation, financial outlook, leadership, creative DNA, and experience, and the highest score in the marketing category determined the award winner.

“Medical Marketing Whiz demonstrated exceptional leadership and vision within the healthcare marketing industry and the willingness to go above and beyond to spur growth”, said Sai Narula, Manager- Delegate Relations, Health 2.0

Lori Werner, Co-Founder of Medical Marketing Whiz and the chief marketing whiz will also be speaking on a panel discussion at the Health 2.0 conference on the topic of the “Impact Of Social Media & Its Repercussions On Mental Health”.

In addition to the Health 2.0 Best Companies Award, Medical Marketing Whiz was also recently named to DotCom magazine’s 2021 Impact Company Of The Year Awards, Company of the Year in the Healthcare Marketing edition of Healthcare Tech Outlook magazine, and certified as one of the Best Places to Work for 2021-22 by Great Places to Work.

About MEDICAL MARKETING WHIZ

Medical Marketing Whiz is the leader in practice growth for doctors in the specialties of OBGYN, urogynecology, aesthetics, and concierge medicine. Lori Werner and Glenn Akins co-founded Medical Marketing Whiz in 2018 and have quickly become one of the most sought-after marketing agencies in North America.

The company serves as an outsourced chief marketing officer for private practice physicians and serves as an extension of the client’s team, implementing a proven marketing system, called the Dr. Marketing Blueprint, that includes social media marketing, email marketing, reputation management, local search engine optimization and patient education events and webinars.

Medical Marketing Whiz’s personalized approach to marketing helps practices grow in-office procedures such as intimate health, aesthetics, or hormone therapy and be known as the go-to expert in their local market.

For more information visit https://www.medicalmarketingwhiz.com/

About Health 2.0 Best Companies Award

Health 2.0 Best Companies Award is awarded to companies who have made impactful contributions and have been leading change in the healthcare sector. Nominees are evaluated in five areas: Industry reputation, creative DNA, financial outlook, competitive edge, and strong leadership. The final score is calculated by arriving at an aggregate of the above 5 grades. This cumulative grade helps to determine the final ranking of the honoree individual or organization.

For more information visit https://www.health2conf.com/be-recognized

Media Contact:
Medical Marketing Whiz
Lori Werner
Co-Founder & Chief Marketing Whiz
lori@medicalmarketingwhiz.com
(888) 418-8065

Media Contact:
Sai Narula
Manager- Delegate Relations, Marketing 2.0
sai@marketing2conf.com
(302) 842-8130

Lori Werner
Medical Marketing Whiz
email us here


Source: EIN Presswire

How to examine moles at home: Review of the NOTA mole tracker

How to examine moles at home: This is a real early diagnosis of skin cancer at the price of a smart watch

Early diagnosis of skin cancer at the price of a smart watch

Early diagnosis of skin cancer at the price of a smart watch. Detailed analysis of the device and the NOTA mole tracker application

This is really an early diagnosis of skin cancer at the price of a smart watch!”

— Karina Babikova

SINGAPORE, Сингапур, October 31, 2021 /EINPresswire.com/ — NOTA mole tracker (https://notamole.com) is a device for the study of moles and the diagnosis of skin cancer, which stands out in a special way among others. For example, this is not a magnifying glass attached to a phone, it is an independent device that uses bioimpedance technology for measurements, i.e. it literally penetrates the skin by 2 mm with a weak electrical pulse and measures the resistance of cells.

Yes, the device has a fairly high price – $300, but if compare, for example, with an annual subscription to the SkinVision app, will get $25 versus $45 monthly. NOTA can measure the moles of all family members, and the application for it is free, supported by almost any device and takes up 50 MB of memory.

Filling and appearance
NOTA is a small black gadget, on one side of which there are removable heads with 4 electrodes. The case material is a pleasant-to-touch plastic covered with soft-touch, which prevents the device from sliding in the hand when measuring a mole.
The sensitive brass electrodes of the device head, which register changes in the cells, are gold-plated to prevent corrosion and increase service life.

Cost.
Propose to close this issue immediately. What need to understand is that are not buying another gadget, but the opportunity to detect cancer at an early stage and cure it. Even have insurance, it's still not easy to make an appointment with an oncodermologist (especially in California), and appointment may be scheduled in 4-5 months. Can use the services of applications that analyze models using AI, but at the end of the review will clearly show why this is pointless. And if have more than 100 moles on body, then using NOTA will pay for itself in the first month and will save a lot of time and nerves, since buy the device once and for a long time.

Appointment
Should immediately note that this is not a medical device, but its results can be a step towards an early meeting with a dermatologist, which will help get rid of possible skin cancer at an early stage, when treatment is limited only to the removal of a mole and follow-up. Therefore, use NOTA also as a 2-opinion after consulting with a dermatologist.

Application
For NOTA to work, need a phone with the NOTA mole tracker app installed, which can be downloaded from the AppStore or Google Play, and Bluetooth.
All moles are stored as a list with brief information – the location of the mole, the time of the last scan, a reminder and an icon with a green or red dot – the result of the last examination. Moles can be sorted by creation time, last scan, and so on.

Experiment
To check the harm that the sun does to our moles, the experimenter sunbathed for 1.5 hours without a protective cream. At the same time, moles on the abdomen appeared under the sun, usually hidden by clothes. Before the tan, NOTA showed that everything was fine with the moles, but after sunbathing, the device showed that something was wrong with the moles. And it was true, because the subject received a slight sunburn, in which the skin was hot, reddened and began to itch. At the same time, the moles were checked using an artificial intelligence-based application, and it showed that everything was fine…

Conclusions from the experiment:
1) The bioimpedance method used by NOTA notices changes in the mole even after a short stay in the sun without protection (sunscreen, clothing).
2) Applications for detecting changes in moles using AI are ineffective. If really need to find out the "fate of the mole from the photo" – send the image to the doctor.
3) Always use sunscreens!
P.S. A day later, when the itching and skin temperature have passed, the experimenter measured the mole again – everything is fine.

Ann Goldberg
Artes Electronics
+1 3156365213
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Early diagnosis of skin cancer at the price of a smart watch


Source: EIN Presswire

Orthobiologics Market Outlook 2021, Share, Size, Trends, Forecast and Analysis of Key players

Orthobiologics Market

Orthobiologics Market

SHERIDAN, WYOMING, UNITED STATES, October 31, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group, titled, “Orthobiologics Market Size: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global orthobiologics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.

Orthobiologics refer to tissue-derived products manufactured by utilizing naturally found substances in the body, such as carbohydrates, proteins, cells, glycoproteins, etc. Some of the widely used orthobiologic therapies include stem cells, platelet-rich plasma (PRP), autologous conditioned plasma (ACP), bone marrow aspirate concentrate (BMAC), etc. They aid in minimizing pain and inflammation, reversing debilitating effects of osteoarthritis, facilitating cartilage regeneration, etc. Orthobiologics also help in the speedy recovery of sports-related injuries among professional and recreational athletes.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Orthobiologics Market Trends:

The growing participation of individuals in physical activities is augmenting the need for orthobiologics to treat numerous sports-related injuries, such rotator cuff tears, shoulder osteoarthritis, knee osteoarthritis, etc. Additionally, the rising geriatric population, who are more prone to age-related osteoporosis, is also propelling the product demand. Besides this, the increasing risk of developing osteoarthritis due to sedentary lifestyles and unhealthy dietary patterns is further catalyzing the global market. Apart from this, the growing need for minimally-invasive orthopedic surgeries and the escalating demand for bioabsorbable implants are further anticipated to fuel the orthobiologic market over the forecasted period.

Request a Free Sample Report: https://www.imarcgroup.com/orthobiologics-market/requestsample

Orthobiologics Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Arthrex Inc, Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries Inc., Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, Wright Medical Group N.V. and Zimmer Biomet.

The report has segmented the market on the basis on product, type, application and end user.

Breakup by Product:

Demineralized Bone Matrix
Allograft
Bone Morphogenetic Protein
Viscosupplementation Products
Synthetic Bone Substitutes
Others

Breakup by Type:

Knee
Ankle
Hip
Wrist and Shoulder
Spine
Others

Breakup by Application:

Osteoarthritis and Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial and Dental Applications

Breakup by End User:

Hospitals and Ambulatory Centers
Research and Academic Institutes
Dental Clinics and Facilities
Orthopedic Clinics

Breakup by Region:

North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://bit.ly/3Gw2y2k

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

Market Performance (2015-2020)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse Other Reports by IMARC Group:

https://sites.google.com/view/healthcare-industry-report/Renal-Denervation-Systems-Market

https://sites.google.com/view/healthcare-industry-report/Infection-Control-Market?authuser=4

https://sites.google.com/view/healthcare-industry-report/Medical-Ceramics-Market

https://sites.google.com/view/healthcare-industry-report/Thermal-Ceramics-Market?authuser=4

https://sites.google.com/view/healthcare-industry-report/Orthobiologics-Market-

https://sites.google.com/view/healthcare-industry-report/microdermabrasion-devices-market

https://sites.google.com/view/healthcare-industry-report/anesthesia-endotracheal-tubes-market

https://sites.google.com/view/healthcare-industry-report/live-cell-imaging-market

https://sites.google.com/view/healthcare-industry-report/autoimmune-disease-diagnosis-market

https://sites.google.com/view/healthcare-industry-report/global-eubiotics-market

https://sites.google.com/view/healthcare-industry-report/Microfluidics-Market

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
email us here


Source: EIN Presswire

Eye Health Supplements Market Report 2021-26: Market Share, Size, Growth, Trends, Forecast

According to the latest report by IMARC Group, The global eye health supplements market to grow at a CAGR of around 6% during the forecast period (2021-2026).

SHERIDAN, WYOMING, UNITED STATE, October 31, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group “Eye Health Supplements Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The global eye health supplements market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the global eye health supplements market to grow at a CAGR of around 6% during the forecast period (2021-2026).

Eye health supplements assist in preserving the vision and maintaining overall eye health. They also minimize the risk of cataracts, age-related macular degeneration (AMD) and other visiondisorders, which may lead to partial or complete blindness. They comprise nutrients like essential fatty acids that are beneficial for proper visual and retinal function. As a result, their demand is escalating across the globe.

Request for a free sample copy of this report: https://www.imarcgroup.com/eye-health-supplements-market/requestsample

Market Trends:

Significant hours spent on computers, tablets, and smartphones are increasing the risk of developing computer vision syndrome (CVS) and myopia. This, along with the growing geriatric population, is positively influencing the sales of eye health supplements worldwide. Apart from this, the increasing awareness among individuals about the alternatives available for preventing different eye conditions is also fueling the growth of the market. Furthermore, governing agencies of various countries are investing in clinical studies to improve the understanding of nutrients on eye health. This is anticipated to offer lucrative opportunities to market players.

Breakup by Ingredient Type:

Lutein and Zeaxanthin
Antioxidants
Omega-3 Fatty Acids
Coenzyme Q10
Flavonoids
Alpha-Lipoic Acid
Others
Breakup by Indication:

Age-related Macular Degeneration (AMD)
Cataract
Dry Eye Syndrome
Inflammation
Others
Breakup by Formulation:

Tablets
Capsules
Powder
Others
Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Competitive Landscape with Key Player:

Alliance Pharma PLC
Amway International (Alticor)
Bausch & Lomb Incorporated
Eyescience Labs
Kemin Industries Inc.
Novartis AG
NutraChamps
Nutrivein
Pfizer Inc.
The Nature’s Bounty Co.
Vitabiotics Ltd.
ZeaVision LLC.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://bit.ly/3eeAogo

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Related Reports

seed treatment market

united states cigarette market

freeze-drying equipment market: https://bit.ly/3ffLuS5

specialty medical chairs market: https://bit.ly/3geB8mN

baby pacifier market: https://bit.ly/3oPKTwh

dashboard camera market: https://bit.ly/3feMG8z

personal mobility devices market: https://bit.ly/2WSrT4e

firefighting foam market: https://bit.ly/3lbDvJg

telecom analytics market: https://bit.ly/3DNuBcl

debt collection software market: https://bit.ly/3iW2GhE

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
email us here


Source: EIN Presswire

Artificial Insemination Market 2021-26: Industry Trends, Share, Size, Growth, Outlook

According to the latest report by IMARC Group, The global artificial insemination market to grow at a CAGR of around 8% during 2021-2026.

SHERIDAN, WYOMING, UNITED STATE, October 31, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group "Artificial Insemination Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", The global artificial insemination market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026.

Artificial insemination refers to an assisted fertilization treatment wherein the sperm is artificially introduced into the cervix and uterus of a female. This procedure is employed through artificial insemination homologous (AIH), artificial insemination donor semen (AID), or intrauterine insemination (IUI). Artificial insemination is beneficial for infertility, old age, poor sperm quality, polycystic ovary syndrome (PCOS), and endometriosis. Other than this, artificial insemination is also adopted in animal breeding to conserve endangered species.

Request for a free sample copy of this report: https://www.imarcgroup.com/artificial-insemination-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends:

The growing rate of infertility, changing lifestyles, and increasing awareness regarding the availability of alternative reproductive treatmentsare majorly driving the global artificial insemination market. The legalization of same-sex marriage by governments of various nations is further contributing to the market growth. Moreover, there has been an increase in the adoption of artificial insemination in the breeding of livestock animals as it is considered more hygienic, thereby preventing the spread of zoonotic diseases. This is also supported by the escalating demand for animal-based proteins.

Breakup by Type:

Intrauterine
Intracervical
Intravaginal
Intratubal
Breakup by Source Type:

AIH-Husband
AID-Donor
Breakup by End Use:

Hospitals and Clinics
Fertility Centers
Others
Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Competitive Landscape with Key Player:

Conceivex Inc.
FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
Genea Limited
Genus plc
Hamilton Thorne Inc.
Hi-Tech Solutions
Kitazato Corporation
Pride Angel
Rinovum Women's Health LLC
Rocket Medical plc
TenderNeeds Fertility LLC
Vitrolife AB.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://bit.ly/3uGpYMO

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Related Reports

kitchen appliances market

hybrid electric vehicle market

spices and seasonings market: https://bit.ly/3ySgNKW

bopp films market: https://bit.ly/33F7KyI

hydrogen generation market: https://bit.ly/3vLu2Lx

affective computing market: https://bit.ly/3uVq1mZ

sodium sulfur battery market: https://bit.ly/2QxIwig

structural insulated panels market: https://bit.ly/3pTCbxD

patient engagement solutions market: https://bit.ly/3a0G6Qs

solid oxide fuel cell market: https://bit.ly/3oUsSLe

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here


Source: EIN Presswire

Medical Foods Market Report 2021-2026: Industry Trends, Share, Size, Growth and Forecast

Medical Foods Market

Medical Foods Market

SHERIDAN, WY, UNITED STATES, October 31, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group, titled, “Medical Foods Market Size: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026″, the medical foods market exhibited moderate growth during 2015-2020. and expected to at a CAGR of around 5% during the next five years

Medical foods are intended to be consumed or administered enterally under the supervision of a physician. Their consumption helps in the specific dietary management of a condition or disease for which distinctive nutritional requirements are prescribed according to a medical evaluation. They are advised to patientswith limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients on account of therapeutic or chronic medical requirements.

Medical Food Market Trends

The growing geriatric population, in confluence with the increasing prevalenceof chronic diseases, represents one of the key factors driving the sales of medical foods across the globe. They help manage symptoms of dementia, multiple sclerosis, and various neurological conditions. Moreover, rising awareness among patients about clinical nutrition is strengthening the growth of the market. Apart from this, the burgeoning e-commerce sector, boosting sales of smart devices and the increasing penetration of the internet haveresulted in the rising purchase of medical foods via online platforms. Other factors propelling the growth of the market includeincreasing funding forresearch and development (R&D) activities by several manufacturers and the rising adoption of healthy alternatives on account of the escalating medical servicescosts.

Request Free Sample Report: https://www.imarcgroup.com/medical-foods-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Medical Foods Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, Alfasigma S.p.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company LLC (Reckitt Benckiser), Medtrition Inc., Meiji Holdings Co. Ltd., Metagenics Inc. (Alticor), Nestlé S.A., Primus Pharmaceuticals Inc., Targeted Medical Pharma Inc. and Victus Inc.

The report has segmented the market on the basis on region, product, route of administration, application and distribution channel.

Breakup by Product:

Pills
Powder
Others

Breakup by Route of Administration:

Oral
Enteral
Breakup by Application:

ADHD
Depression
Diabetes
Cancer
Alzheimer’s Disease
Metabolic Disorders
Others
Breakup by Distribution Channel:

Supermarkets
Hospital and Retail Pharmacies
Online Pharmacies
Others
Breakup by Region:

North America: (United States, Canada)
Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, RussiaOthers
Latin America: (Brazil, Mexico,Others)
Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://bit.ly/3nDTeB0

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Browse related reports:

https://sites.google.com/view/healthcare-industry-report/thyroid-function-test-market-size-share-industry-report

https://sites.google.com/view/healthcare-industry-report/hematologic-malignancies-treatment-market-growth-trends-report

https://sites.google.com/view/healthcare-industry-report/hormonal-contraceptive-market-size-share-industry-forecast-2021-26

https://sites.google.com/view/healthcare-industry-report/enteric-softgel-capsules-market-trends-and-forecast-to-2026

https://sites.google.com/view/healthcare-industry-report/eye-testing-equipment-market-sizeshare-industry-growth-2026

https://sites.google.com/view/healthcare-industry-report/Microfluidics-Market

https://sites.google.com/view/healthcare-industry-report/global-eubiotics-market

https://sites.google.com/view/healthcare-industry-report/live-cell-imaging-market

https://sites.google.com/view/healthcare-industry-report/autoimmune-disease-diagnosis-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here


Source: EIN Presswire

Nuclear Medicine Equipment Market Research Report 2021, Size, Share, Analysis and Forecast

Nuclear Medicine Equipment Market

SHERIDAN, WYOMING, UNITED STATES, October 31, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group, titled “Nuclear Medicine Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the market to grow at a CAGR of XX% during 2021-2026.

Nuclear medicine equipment is a medical device, which is utilized extensively in the healthcare industry for treating and diagnosing several diseases, such as cancer, and cardiovascular and neurological disorders, by generating anatomical images. These devices are further used for developing drugs and examining various processes of tissue blood flow, cell receptor expression, neurotransmitter activity, abnormal cell and metabolism of the patient.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Nuclear Medicine Equipment Market Trends:

The increasing requirement for personalized medicines in the healthcare sector and the rising prevalence of chronic diseases amongst the geriatric population are primarily driving the nuclear medicine equipment market. Moreover, the widespread adoption of various technologically advanced systems, such as radiotracers and imaging systems and significant investments in research and development (R&D) activities in the field of biotechnology are propelling the market growth. Other factors, such as overall improvement in the medical infrastructure and the rising utilization of position emission tomography (PET) and single-photon emission computed tomography (SPECT) for capturing accurate nuclear medicine imaging, are creating a positive outlook in the market across the globe.

Request Free Sample Report: https://www.imarcgroup.com/nuclear-medicine-equipment-market/requestsample

Nuclear Medicine Equipment Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH and Toshiba Corporation.

The report has segmented the market on the basis on region, disc type, material type and end user.

Breakup by Product:
• Single-Photon Emission Computed Tomography
o Standalone
o Hybrid

• Positron Emission Tomography
o Standalone
o Hybrid

• Planar Scintigraphy

Breakup by Application:
• Neurology
• Oncology
• Cardiology
• Others

Breakup by End User:
• Hospitals
• Imaging Centers
• Academic and Research Institutes
• Others

Breakup by Region:
• North America
o United States
o Canada

• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others

• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others

• Latin America
o Brazil
o Mexico
o Others

• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/nuclear-medicine-equipment-market

Key highlights of the report:
• Market Performance (2015-2020)
• Market Outlook (2021-2026)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Other Reports:

https://www.briefingwire.com/pr/power-electronics-market-2021-26-size-share-trends-industry-analysis-and-research-report

https://www.briefingwire.com/pr/pen-needles-market-report-2021-industry-share-trends-analysis-growth-scope-future-scope-2026

https://www.briefingwire.com/pr/load-balancer-market-report-2021-size-share-trends-growth-and-future-scope-2026

https://www.briefingwire.com/pr/dairy-snacks-market-research-report-2021-share-growth-analysis-demand-forecast-2026

https://www.briefingwire.com/pr/electric-hair-brush-market-2021-26-overview-size-share-opportunities-demand-and-research-report

https://www.briefingwire.com/pr/smart-mining-market-report-2021-industry-trends-size-growth-share-price-scope-forecast-2026

http://www.briefingwire.com/pr/kosher-food-market-research-report-2021-overview-size-share-trends-analysis-future-scope-2026

https://www.briefingwire.com/pr/automotive-sunroof-market-report-2021-size-share-trends-growth-forecast-2026

http://www.briefingwire.com/pr/lateral-fitness-equipment-market-2021-overview-share-size-opportunities-demand-forecast-2026

http://www.briefingwire.com/pr/pyrogen-testing-market-2021-overview-size-share-trends-opportunities-forecast-2026

https://briefingwire.com/pr/gas-chromatography-market-2021-industry-growth-size-share-trends-demand-forecast-2026

https://www.briefingwire.com/pr/data-preparation-market-report-2021-trends-growth-analysis-demand-and-forecast-2026

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here


Source: EIN Presswire

Pyrogen Testing Market 2021-26: Industry Analysis, Size, Share, Growth and Forecast

Pyrogen Testing Market

SHERIDAN, WYOMING, UNITED STATES, October 31, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group, titled “Pyrogen Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the market to grow at a CAGR of XX% during 2021-2026.

Pyrogen testing refers to the detection of both endotoxin and non-endotoxin pyrogenic contaminants in aqueous parenteral. It assists in the safety of parenteral pharmaceutical products and medical devices. Pyrogen testing aids in avoiding life-threatening diseases and fatal endotoxic shock induced by pyrogenic substances. Some commonly used methods of pyrogen testing include the Limulus amebocyte lysate (LAL) test, recombinant factor C (rFC) test, rabbit pyrogen test (RPT), etc.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Pyrogen Testing Market Trends:

The expanding pharmaceutical and biotechnology industries are primarily driving the pyrogen testing market. Furthermore, pyrogen testing aids in enhancing the management of infectious diseases by determining the disease severity, recovery, and sequelae, along with being used in the production of novel COVID-19 vaccines. This, in turn, is also propelling the market growth. Besides this, the growing prevalence of chronic ailments, including heart diseases, cancer, diabetes, etc., is further augmenting the growth of the market. Moreover, several key players are introducing technologically advanced and cost-effective pyrogen testing techniques that provide a more relevant prediction of pyrogenic activity. In addition to this, the launch of the new therapeutics and extensive R&D activities by manufacturing companies are further anticipated to catalyze the pyrogen testing market in the coming years.

Request Free Sample Report: https://www.imarcgroup.com/pyrogen-testing-market/requestsample

Pyrogen Testing Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Charles River Laboratories International Inc., Ellab A/S, Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation), Lonza Group AG, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories LLC (Sotera Health), North American Science Associates Inc., Pacific Biolabs Inc., Sanquin, Thermo Fisher Scientific Inc, Toxikon Corporation and Wuxi Apptec.

The report has segmented the market on the basis on region, disc type, material type and end user.

Breakup by Product:
• Instruments
• Kits and Reagents
• Services

Breakup by Test Type:
• In-vitro Tests
• LAL Tests
• Rabbit Tests
• Others

Breakup by Application:
• Pharmaceutical and Biologics
• Medical Devices
• Others

Breakup by Region:
• North America
o United States
o Canada

• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others

• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others

• Latin America
o Brazil
o Mexico
o Others

• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pyrogen-testing-market

Key highlights of the report:
• Market Performance (2015-2020)
• Market Outlook (2021-2026)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Other Reports:

https://area-info.net/europe-artificial-intelligence-market-2021-share-size-trends-opportunities-and-forecast-2026/

https://area-info.net/europe-biodegradable-plastic-market-report-2021-industry-growth-share-trends-analysis-and-forecast-2026/

https://area-info.net/gcc-healthcare-packaging-market-2021-size-share-trends-analysis-growth-and-forecast-2026/

https://area-info.net/china-electric-vehicle-battery-market-report-2021-share-trends-growth-analysis-and-forecast-2026/

https://area-info.net/india-electric-vehicle-battery-market-report-2021-2026-industry-trends-share-size-demand-and-forecast/

https://area-info.net/latin-america-artificial-intelligence-market-report-2021-26-industry-growth-market-share-size-trends/

https://area-info.net/united-states-artificial-intelligence-market-2021-size-share-growth-analysis-and-forecast-2026/

https://area-info.net/latin-america-telehealth-market-2021-2026-industry-trends-size-share-growth-and-forecast-analysis/

https://area-info.net/united-states-frozen-meat-market-size-2021-share-analysis-demand-growth-and-forecast-2026/

https://area-info.net/north-america-hemp-market-report-2021-size-share-analysis-growth-and-forecast-2026/

https://area-info.net/japan-organic-cosmetics-market-2021-industry-analysis-share-trends-growth-and-forecast-2026/

https://area-info.net/japan-functional-drinks-market-report-2021-share-trends-growth-opportunities-and-forecast-2026/

https://area-info.net/europe-cbd-oil-market-report-2021-share-analysis-growth-analysis-and-forecast-2026/

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here


Source: EIN Presswire